Parallel Advisors’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.4K | Hold |
1,705
| – | – | ﹤0.01% | 1734 |
|
|
2025
Q1 | $50.3K | Buy |
1,705
+515
| +43% | +$15.2K | ﹤0.01% | 1618 |
|
|
2024
Q4 | $34.6K | Sell |
1,190
-187
| -14% | -$5.44K | ﹤0.01% | 1849 |
|
|
2024
Q3 | $63.2K | Buy |
1,377
+1,331
| +2,893% | +$61.1K | ﹤0.01% | 1478 |
|
|
2024
Q2 | $1.88K | Buy |
46
+29
| +171% | +$1.19K | ﹤0.01% | 2811 |
|
|
2024
Q1 | $434 | Hold |
17
| – | – | ﹤0.01% | 3073 |
|
|
2023
Q4 | $154 | Sell |
17
-305
| -95% | -$2.76K | ﹤0.01% | 3196 |
|
|
2023
Q3 | $2.05K | Buy |
+322
| New | +$2.05K | ﹤0.01% | 2808 |
|
|
2023
Q2 | – | Sell |
-91
| Closed | -$1.4K | – | 3491 |
|
|
2023
Q1 | $1.4K | Buy |
91
+70
| +333% | +$1.08K | ﹤0.01% | 2874 |
|
|
2022
Q4 | $466 | Sell |
21
-6
| -22% | -$133 | ﹤0.01% | 3044 |
|
|
2022
Q3 | $0 | Buy |
27
+6
| +29% | – | ﹤0.01% | 3434 |
|
|
2022
Q2 | $0 | Buy |
+21
| New | – | ﹤0.01% | 3290 |
|
|
2022
Q1 | – | Sell |
-171
| Closed | -$4K | – | 3229 |
|
|
2021
Q4 | $4K | Buy |
171
+161
| +1,610% | +$3.77K | ﹤0.01% | 2500 |
|
|
2021
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 3207 |
|
|
2021
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 3025 |
|
|
2021
Q1 | $0 | Buy |
+10
| New | – | ﹤0.01% | 2871 |
|